Sphere Medical Share Discussion Threads

[johnlewis79] 10/7/2019 07:39

W hands over control of his 15% stake in Eve Sleep.ES is among 20 Cos W has cut his interests in.
Net Scientific (10%) has also gone to Jupiter Asset Management along with Eve.
Yet another blow to W as Stobart Group issued a profit warning yesterday, W has a 24% stake. Barratt another W investment updates invstrs today.

[johnlewis79] 09/7/2019 19:48

Clients of HL have been stopped from transferring funds trapped in Ws EI fund into other more productive funds or asset classes.

[johnlewis79] 08/7/2019 06:19

.....don't think ordinary shareholders will see any return (waterloo). WPCT hold c.42% in SMH (134m) but he's used to losing money these days so won't bat an eyelid. I have spoken to Wright in the past but he's always very non committal about progress etc. We will have to wait and see and hope for the best. Behind the scenes Sphere could be ready for take off if they
have US reg approval but from memory this was likely to be 2020. We should be ok for the other
£4m if W thinks sufficient progress has been made on extra analytes and auto.
I recently read that W is a very 'hands off' owner
and never fully understood the businesses he invested in. Maybe. However as long as we have funds for another 12-18 months and development costs must be at a minimum now....who knows orders might be piling up and we can start to shift some devices, at least get them into hospitals ICUs for starters.

[del44] 07/7/2019 13:46

Rant certainly not in need of an apology JL...
The sales stuff all stopped when taken private.....I remember reading that someone once came up with the idea of a home computer back in the 60's...but it wasn't till Amstrad came along in the mid 80's...when the time was right.
Proxima...could still be a head of its self for now.....I still see it as been of benefit on an ICU...if only for certain patients who fit a criteria......
DD contacted the company recently...they said nothing much...results been released some time before Autumn....I think...

[waterloo01] 07/7/2019 06:59

2nd nature for a palace fan. Don't hold but has anyone spoken to the company direct to get s sence of where they are? I doubt however that current holders of ordinary shares will see any return though.

[johnlewis79] 07/7/2019 06:19

Apologies for the rant guys n'gals but sometimes yo just gotta scream!

[johnlewis79] 07/7/2019 06:15

what do you think the cost is of transfusing 2 units of blood? P does it for practically nil cost if your taking multiple samples (c.£200 for the sensor x nos of tests / no blood loss). Otherwise £700+ via the conventional method for two units. The Mayo Clinic reckon the true cost of transfusing red blood cells is £775 for a single unit. The economic case is undeniable not to mention the clinical one, ie more frequent testing is desirable in order to detect deteriorating conditions. The economic case is self evident the clinical absolutely (staff cover / gas analyser availability) better outcomes for patients etc.. So here we are stuck in a private Co that is unable or can't be bothered to sell one bloody P device. As i said we need answers.

[johnlewis79] 07/7/2019 05:52

Remember Dr Tom Clutton-Brock? Who most thought was Spheres CEO or rather should have been! Big mistake not getting him on the Co payroll for he was an early enthusiast of Ps ability to carry out frequent measurements of blood samples. There is a very good article titled 'Beyond point-of-care BG analysis' by G.Troughton VP Business Development (ex Sphere) for anyone not up to speed on the whys'n wherefores. I recommend you track it down. Wherefore art thou Dr C-Brock?

[johnlewis79] 07/7/2019 05:31

I'm sure Sphere has value.
It's just how much. For instance the Proxima miniature sensors and monitors could be used for other applications as many have said and importantly Sphere retains intellectual property rights. If W has any intention to re list which I very much doubt he must
be carrying Sphere on his books at a price or at the least know what the Co could receive in a sale.
Maybe it's zero...I dont know. Since the IPO in 2013 Sphere had raised in excess of £60m by April 2015, subsequent raises probably now total £70-80m. At one time the Co was worth £25m+ and that's at the P3 stage. Much has been achieved since then.
Goodness knows what the Sales Manager had been doing since then? Probably still looking for a partner or new distribution channels. (Remember Ortho swerving the global distribution rights to P?) Those few hospitals that showed an interest must be wondering what the hell is going on.
Are we still supplying P to Germany where Sphere made their first sale of P3 in 2/16 (Sp 8p). Most likely not. We need answers and quick but are unlikely to be told much if anything. As i've said before this whole debacle has been orchestrated by you know who!

[del44] 06/7/2019 13:41

ripley94.
It is a private company now.. You still hold shares in a private company, which has 141 million ordinary shares in issue..
However the company has fund raised by issuing preference shares since...there is a number of them in issue as well....

Number of Shares
Sphere Medical Holding Limited has in issue 141,757,872 Ordinary Shares of nominal value £0.01 each and 179,912,380 Preferred Shares of nominal value £0.01 each.

Sphere Medical Limited as in issue 2,159,485 Ordinary Shares, 4,075,800 Convertible Preference Shares, 2,012,000 Convertible B Preferred Shares and 713,934 A Ordinary Shares.
Presently you can not trade any of the above securities.......

[ripley94] 06/7/2019 12:19

Sorry that was preference shares , told last year by the company they are the ones to hold ?
Was there another fund raise last year ?
As not listed no information from broker where my shares just seem to sit in limbo .
From a note i have appears i bought more towards the end i must of been going mad August 2017 early September 2017 lol

[ripley94] 06/7/2019 11:52

Was surprised to see comment on this one on any chat site .
Are my shares worth anything .
Looks like i should of switched to the reference shares when they delisted am i correct thinking that ?

[del44] 05/7/2019 20:32

I would be surprised indeed if SPHR were in the books at any value....

[johnlewis79] 05/7/2019 05:54

Anyone care to figure out WPCT nav? Didn't think so with so many unquoted in the fund you may as well throw dice. I suppose there is a method but W will not tell us outside of them valuing nav every day currently 81! That won't do. It's hardly reassuring for holders in WPCT, let alone others stranded in ex listed Companies. I certainly would not place too much credence on nos coming from W funds atm. Whether this debacle at EI has blown a hole in the Chinese Walls, i don't know and most likely will never know. Anything to do with Sphere is a trade secret especially the valuation, I take it.....it has value? Why not tell us? Were all big boys we can stand heing told the Co is worth a monkey or so!!

[johnlewis79] 04/7/2019 07:50

W is thought to have dumped his entire stake in Stobart Group raising c. £70m.

[johnlewis79] 04/7/2019 07:11

Ws EI fund is closed for another 28 days. Staff redundancies are on the cards. W is still taking in fees as his investors face the prospect of a rush for the exits come 'opening time'.
Redemption pressures, fire sales and contagion could easily damage the the financial system warned the deputy gov of the BOE.
W invstmnt managmnt have until July 29 to make a further update to investors.

[del44] 02/7/2019 21:11

I was talking in hospital about this Proxima...any some of the newer doctors thought it was good...Younger doctors regularly use their phones to understand better about a possible patient diagnose...They are on their phone as much as seeing the patients...
One of the older consultants thought it would be great in a hospital system that didnt have to spend huge amounts of there budgets on drugs and pharmacy companies....
He is very modern in his thinking...and yet, when he gives lectures...he still prefers to use a flip chart and write down his own notes in front of junior doctors....he can use but chose not to use technology.
He thinks the current system is good in general circumstances...but could have its advantages for certain high risk patients.....

[cellis94] 02/7/2019 13:59

I mention about a month ago that P5 had to be automated, ie constantly monitoring the blood gases and warn of slow or sudden changes that would indicate that all is not well with the patient. My son-in-law lost his brother to sepsis a blood flow problem in his bowl lead to infection then sepsis a condition that shouldn't be terminal

[johnlewis79] 02/7/2019 06:20

Agree cellis but more to the point Hospitals never bght into P3 preferring the stone age method of blood analysis. I wonder whether anything has changed apart from P5 now being the super de luxe model which one would think the profession would heartilly endorse after all its been 3 years so enuff time to sign an order for one device. Well maybe not as Sphere is not in the game of selling P.
Bit of a waste of everyone's time and effort. Maybe W will get out of gaol parading Sphere as a great British success story. Could be but in the real world we have missed that and succeeding boats. W will be extremely lucky to get his money back, pis will lose big-time.

[cellis94] 01/7/2019 17:53

The crux of the matter for Sphere will be the point at which it needs another cash injection of cash , at the moment I would say he would definitely not put his hand into his pocket again if he was able to see that he will get a return on his investment . At this stage the likes of you and I have no idea as to the state of play , whereas he knows everything that will enable him to make that decision and all the other investors will just have to sit tight and pray

[johnlewis79] 30/6/2019 06:46

SM had c. 20 patents covering micro analyser and other aspects such as manuf process & trade secrets. Fifteen patents were transferred to SM back in 2002 two have expired and the balance due in 2017 & 2019.Since inception a further 11 have have been granted expiry dates ranging from 2024 and 2031 with others awaiting grant. Some related to product focus,others potential future development plans, extra measurement parameters etc.. I guess were fully protected through the 2020-2031 which should de-risk P5.

[johnlewis79] 29/6/2019 06:57

Says a true believer! Shame Sphere gets tarred with the same brush as some of his 'out there' bios barely at the commercial stage. Tough I know but should we really be here at all and has the delisting improved Sphere's chance of ever making it? Who knows? We might hear something before Xmas....

[del44] 28/6/2019 20:52

He will circle the wagons around the jewel that is Sphere....:-)

[johnlewis79] 28/6/2019 12:24

The scummy hedgies are circulating WPCT hoping to buy distressed assets on the cheap cheap...that's capitalism for you. Probably get a couple of quid for SM if he's lucky..

[johnlewis79] 28/6/2019 06:40

W sells his 20% stake in Ultrahaptics a Bristol tech Co once valued at £150m. He will take a 30% hit on his last round of raises. An existing ii will pick up his stock.